Summary
Amgen Inc. announced on May 15, 2007, that it plans to utilize its commercial paper program to fund the repurchase of its common stock. The company intends to draw down on its commercial paper facility and is exploring additional borrowing options to fully fund its authorized stock repurchase programs for the current year. As of May 14, 2007, Amgen had approximately $5 billion authorized for stock repurchases and $1.2 billion available under its commercial paper program. This announcement signals a significant capital allocation strategy focused on returning value to shareholders through share buybacks, potentially indicating management's confidence in the company's financial health and future prospects.
Key Highlights
- 1Amgen Inc. plans to use its commercial paper program to fund stock repurchases.
- 2The company is exploring additional borrowing opportunities to fully fund authorized share buybacks for the year.
- 3As of May 14, 2007, approximately $5 billion was authorized for stock repurchases.
- 4Amgen had $1.2 billion available under its commercial paper program on May 14, 2007.
- 5The announcement signifies a capital allocation strategy aimed at returning value to shareholders.
- 6Management may be signaling confidence in the company's financial position and future outlook.